Gline Matthewinsider trades

In SEC Form 4 filings, Gline Matthew is listed as CEO of Roivant Sciences Ltd. (ROIV). Gline Matthew reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 20.

Companies and roles

Company	Role	Transactions	Last filed
ROIVRoivant Sciences Ltd.	CEO	2	Oct 20

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ROIVRoivant Sciences Ltd.	Oct 16	Oct 20	F	34,638	$33.53	$1,161,412	16,549,136	No	Form 4
ROIVRoivant Sciences Ltd.	Sep 30	Oct 2	F	76,171	$36.57	$2,785,573	16,583,774	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.